JP7682453B2 - 血糖制御システム - Google Patents

血糖制御システム Download PDF

Info

Publication number
JP7682453B2
JP7682453B2 JP2022502591A JP2022502591A JP7682453B2 JP 7682453 B2 JP7682453 B2 JP 7682453B2 JP 2022502591 A JP2022502591 A JP 2022502591A JP 2022502591 A JP2022502591 A JP 2022502591A JP 7682453 B2 JP7682453 B2 JP 7682453B2
Authority
JP
Japan
Prior art keywords
subject
therapy
insulin
glucose
control system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2022502591A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022541491A5 (https=
JP2022541491A (ja
Inventor
エル－ハティブ，フィラース，エイチ．
ダミアーノ，エドワード，アール．
ラスキン，エドワード，ビー．
Original Assignee
ベータ バイオニクス，インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2020/042195 external-priority patent/WO2021011697A1/en
Priority claimed from PCT/US2020/042198 external-priority patent/WO2021011699A1/en
Application filed by ベータ バイオニクス，インコーポレイテッド filed Critical ベータ バイオニクス，インコーポレイテッド
Publication of JP2022541491A publication Critical patent/JP2022541491A/ja
Publication of JP2022541491A5 publication Critical patent/JP2022541491A5/ja
Application granted granted Critical
Publication of JP7682453B2 publication Critical patent/JP7682453B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H15/00—ICT specially adapted for medical reports, e.g. generation or transmission thereof
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/60—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to nutrition control, e.g. diets
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
    • A61B5/6802—Sensor mounted on worn items
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/74—Details of notification to user or communication with user or patient; User input means
    • A61B5/742—Details of notification to user or communication with user or patient; User input means using visual displays
    • A61B5/743—Displaying an image simultaneously with additional graphical information, e.g. symbols, charts, function plots
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M2005/14208—Pressure infusion, e.g. using pumps with a programmable infusion control system, characterised by the infusion program
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
    • A61M5/14248—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type
    • A61M2005/14252—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type with needle insertion means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
    • A61M2005/1726—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure the body parameters being measured at, or proximate to, the infusion site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/16—General characteristics of the apparatus with back-up system in case of failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3546—Range
    • A61M2205/3553—Range remote, e.g. between patient's home and doctor's office
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3546—Range
    • A61M2205/3561—Range local, e.g. within room or hospital
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
    • A61M2205/3584—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using modem, internet or Bluetooth®
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
    • A61M2205/3592—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using telemetric means, e.g. radio or optical transmission
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/502—User interfaces, e.g. screens or keyboards
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/502—User interfaces, e.g. screens or keyboards
    • A61M2205/505—Touch-screens; Virtual keyboard or keypads; Virtual buttons; Soft keys; Mouse touches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/52—General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/20—Blood composition characteristics
    • A61M2230/201—Glucose concentration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Business, Economics & Management (AREA)
  • General Business, Economics & Management (AREA)
  • Nutrition Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pathology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Surgery (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
JP2022502591A 2019-07-16 2020-07-16 血糖制御システム Active JP7682453B2 (ja)

Applications Claiming Priority (35)

Application Number Priority Date Filing Date Title
US201962874972P 2019-07-16 2019-07-16
US201962874975P 2019-07-16 2019-07-16
US201962874928P 2019-07-16 2019-07-16
US201962874934P 2019-07-16 2019-07-16
US201962874968P 2019-07-16 2019-07-16
US201962874977P 2019-07-16 2019-07-16
US201962874950P 2019-07-16 2019-07-16
US201962874959P 2019-07-16 2019-07-16
US201962874954P 2019-07-16 2019-07-16
US201962874964P 2019-07-16 2019-07-16
US62/874,968 2019-07-16
US62/874,964 2019-07-16
US62/874,950 2019-07-16
US62/874,959 2019-07-16
US62/874,975 2019-07-16
US62/874,954 2019-07-16
US62/874,928 2019-07-16
US62/874,977 2019-07-16
US62/874,934 2019-07-16
US62/874,972 2019-07-16
US201962911017P 2019-10-04 2019-10-04
US201962910970P 2019-10-04 2019-10-04
US201962911143P 2019-10-04 2019-10-04
US62/911,017 2019-10-04
US62/910,970 2019-10-04
US62/911,143 2019-10-04
US202062987842P 2020-03-10 2020-03-10
US62/987,842 2020-03-10
US202063037472P 2020-06-10 2020-06-10
US63/037,472 2020-06-10
USPCT/US2020/042198 2020-07-15
PCT/US2020/042195 WO2021011697A1 (en) 2019-07-16 2020-07-15 Blood glucose control system
USPCT/US2020/042195 2020-07-15
PCT/US2020/042198 WO2021011699A1 (en) 2019-07-16 2020-07-15 Ambulatory device and components thereof
PCT/US2020/042269 WO2021011738A1 (en) 2019-07-16 2020-07-16 Blood glucose control system

Publications (3)

Publication Number Publication Date
JP2022541491A JP2022541491A (ja) 2022-09-26
JP2022541491A5 JP2022541491A5 (https=) 2023-07-25
JP7682453B2 true JP7682453B2 (ja) 2025-05-26

Family

ID=74211371

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022502591A Active JP7682453B2 (ja) 2019-07-16 2020-07-16 血糖制御システム

Country Status (10)

Country Link
US (7) US11116902B2 (https=)
EP (1) EP3998943A4 (https=)
JP (1) JP7682453B2 (https=)
CN (1) CN114760918A (https=)
AU (1) AU2020314831A1 (https=)
CA (1) CA3146965C (https=)
DE (1) DE112020003392T5 (https=)
IL (1) IL289857A (https=)
MX (1) MX2022000670A (https=)
WO (1) WO2021011738A1 (https=)

Families Citing this family (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8417311B2 (en) 2008-09-12 2013-04-09 Optiscan Biomedical Corporation Fluid component analysis system and method for glucose monitoring and control
CA2702116C (en) 2007-10-10 2021-01-05 Optiscan Biomedical Corporation Fluid component analysis system and method for glucose monitoring and control
US7959598B2 (en) 2008-08-20 2011-06-14 Asante Solutions, Inc. Infusion pump systems and methods
US9561324B2 (en) 2013-07-19 2017-02-07 Bigfoot Biomedical, Inc. Infusion pump system and method
GB2523989B (en) 2014-01-30 2020-07-29 Insulet Netherlands B V Therapeutic product delivery system and method of pairing
CN111905188B (zh) 2015-02-18 2022-07-22 英赛罗公司 流体输送和输注装置及其使用方法
WO2017027459A1 (en) 2015-08-07 2017-02-16 Trustees Of Boston University Glucose control system with automatic adaptation of glucose target
WO2017123525A1 (en) 2016-01-13 2017-07-20 Bigfoot Biomedical, Inc. User interface for diabetes management system
HK1256995A1 (zh) 2016-01-14 2019-10-11 Bigfoot Biomedical, Inc. 药物输送设备、系统和方法中的阻塞解决方案
US10806859B2 (en) 2016-01-14 2020-10-20 Bigfoot Biomedical, Inc. Adjusting insulin delivery rates
US12383166B2 (en) 2016-05-23 2025-08-12 Insulet Corporation Insulin delivery system and methods with risk-based set points
US20170348479A1 (en) 2016-06-03 2017-12-07 Bryan Choate Adhesive system for drug delivery device
US10765807B2 (en) 2016-09-23 2020-09-08 Insulet Corporation Fluid delivery device with sensor
US11096624B2 (en) 2016-12-12 2021-08-24 Bigfoot Biomedical, Inc. Alarms and alerts for medication delivery devices and systems
US10881792B2 (en) 2017-01-13 2021-01-05 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
US11033682B2 (en) 2017-01-13 2021-06-15 Bigfoot Biomedical, Inc. Insulin delivery methods, systems and devices
US10500334B2 (en) 2017-01-13 2019-12-10 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
US10758675B2 (en) 2017-01-13 2020-09-01 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
EP3568860B1 (en) 2017-01-13 2025-12-10 Insulet Corporation Insulin delivery methods, systems and devices
US10583250B2 (en) 2017-01-13 2020-03-10 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
USD928199S1 (en) 2018-04-02 2021-08-17 Bigfoot Biomedical, Inc. Medication delivery device with icons
US11565043B2 (en) 2018-05-04 2023-01-31 Insulet Corporation Safety constraints for a control algorithm based drug delivery system
US12562251B1 (en) 2018-05-09 2026-02-24 Bigfoot Biomedical, Inc. Computing architecture for assuring the provenance of medication therapy related parameters, and related systems, methods and devices
US11725741B2 (en) 2018-07-17 2023-08-15 Insulet Corporation Low force valves for drug delivery pumps
AU2019347755B2 (en) 2018-09-28 2023-02-02 Insulet Corporation Activity mode for artificial pancreas system
EP3864668A1 (en) 2018-10-11 2021-08-18 Insulet Corporation Event detection for drug delivery system
WO2020097552A1 (en) 2018-11-08 2020-05-14 Capillary Biomedical, Inc Linear insertion device with rotational drive
USD920343S1 (en) 2019-01-09 2021-05-25 Bigfoot Biomedical, Inc. Display screen or portion thereof with graphical user interface associated with insulin delivery
US11957876B2 (en) 2019-07-16 2024-04-16 Beta Bionics, Inc. Glucose control system with automated backup therapy protocol generation
WO2021011697A1 (en) 2019-07-16 2021-01-21 Beta Bionics, Inc. Blood glucose control system
EP3998943A4 (en) 2019-07-16 2023-09-06 Beta Bionics, Inc. Blood glucose control system
US11801344B2 (en) 2019-09-13 2023-10-31 Insulet Corporation Blood glucose rate of change modulation of meal and correction insulin bolus quantity
US11935637B2 (en) 2019-09-27 2024-03-19 Insulet Corporation Onboarding and total daily insulin adaptivity
CN114868200A (zh) * 2019-10-04 2022-08-05 贝塔仿生公司 血糖控制系统
EP4069082B1 (en) 2019-12-06 2024-06-05 Insulet Corporation Techniques and devices providing adaptivity and personalization in diabetes treatment
US11833329B2 (en) 2019-12-20 2023-12-05 Insulet Corporation Techniques for improved automatic drug delivery performance using delivery tendencies from past delivery history and use patterns
JP7512395B2 (ja) 2020-01-06 2024-07-08 インスレット コーポレイション 持続する残差に基づく食事および／または運動行為の予測
EP4100958A1 (en) 2020-02-03 2022-12-14 Insulet Corporation Use of fuzzy logic in predicting user behavior affecting blood glucose concentration
US11551802B2 (en) 2020-02-11 2023-01-10 Insulet Corporation Early meal detection and calorie intake detection
US11986630B2 (en) 2020-02-12 2024-05-21 Insulet Corporation Dual hormone delivery system for reducing impending hypoglycemia and/or hyperglycemia risk
US11547800B2 (en) 2020-02-12 2023-01-10 Insulet Corporation User parameter dependent cost function for personalized reduction of hypoglycemia and/or hyperglycemia in a closed loop artificial pancreas system
US11324889B2 (en) 2020-02-14 2022-05-10 Insulet Corporation Compensation for missing readings from a glucose monitor in an automated insulin delivery system
US12495994B2 (en) 2020-02-20 2025-12-16 Insulet Corporation Meal bolus subcategories in model based insulin therapy
US11607493B2 (en) 2020-04-06 2023-03-21 Insulet Corporation Initial total daily insulin setting for user onboarding
US11690955B2 (en) * 2020-04-23 2023-07-04 Medtronic Minimed, Inc. Continuous analyte sensor quality measures and related therapy actions for an automated therapy delivery system
US12575797B2 (en) 2020-06-11 2026-03-17 Willow Laboratories, Inc. Blood glucose disease management system
US12121700B2 (en) 2020-07-22 2024-10-22 Insulet Corporation Open-loop insulin delivery basal parameters based on insulin delivery records
US11684716B2 (en) 2020-07-31 2023-06-27 Insulet Corporation Techniques to reduce risk of occlusions in drug delivery systems
KR20260019029A (ko) 2020-08-27 2026-02-09 인슐렛 코포레이션 웨어러블 미소 투여 약물 전달 디바이스
US12214159B2 (en) 2020-08-28 2025-02-04 Tandem Diabetes Care, Inc Insulin infusion set
US20220062546A1 (en) * 2020-08-31 2022-03-03 Insulet Corporation Adjusting settings to different degrees of aggressiveness in an automated insulin delivery system based on quality of blood glucose level control by a user
US12569619B2 (en) 2020-09-21 2026-03-10 Insulet Corporation Techniques for determining automated insulin delivery dosages
US12115351B2 (en) 2020-09-30 2024-10-15 Insulet Corporation Secure wireless communications between a glucose monitor and other devices
EP4696344A3 (en) 2020-09-30 2026-04-15 Insulet Corporation Drug delivery device with integrated optical-based glucose monitor
US11594314B2 (en) 2020-12-07 2023-02-28 Beta Bionics, Inc. Modular blood glucose control systems
US12491310B2 (en) 2021-01-12 2025-12-09 Insulet Corporation Wearable drug delivery device with removal element
US11160925B1 (en) 2021-01-29 2021-11-02 Insulet Corporation Automatic drug delivery system for delivery of a GLP-1 therapeutic
WO2022164690A1 (en) * 2021-01-29 2022-08-04 Insulet Corporation Techniques and devices that adapt basal profiles for drug delivery applications
USD1059372S1 (en) * 2021-12-03 2025-01-28 Abbott Diabetes Care Inc. Display screen or portion thereof with graphical user interface
EP4305633A1 (en) * 2021-03-09 2024-01-17 Insulet Corporation Opportunistic retrieval of analyte value to improve automatic drug control accuracy
US11904140B2 (en) 2021-03-10 2024-02-20 Insulet Corporation Adaptable asymmetric medicament cost component in a control system for medicament delivery
EP4305636A1 (en) 2021-03-10 2024-01-17 Insulet Corporation A medicament delivery device with an adjustable and piecewise analyte level cost component to address persistent positive analyte level excursions
JP2024535653A (ja) * 2021-03-19 2024-10-01 ユニバーシティ オブ バージニア 低血糖症リスクを特定および予測するためのシステムおよび方法
WO2022204705A1 (en) * 2021-03-25 2022-09-29 Beta Bionics, Inc. Emergency medicament dose control
US12465686B2 (en) 2021-03-25 2025-11-11 Beta Bionics, Inc. Emergency medicament dose control
US12592306B2 (en) 2021-04-28 2026-03-31 Insulet Corporation Devices and methods for initialization of drug delivery devices using measured analyte sensor information
US12496398B2 (en) 2021-05-28 2025-12-16 Insulet Corporation Threshold based automatic glucose control response
EP4101482A1 (en) 2021-06-07 2022-12-14 Insulet Corporation Exercise safety prediction based on physiological conditions
US20220401640A1 (en) * 2021-06-17 2022-12-22 Icu Medical, Inc. Intravenous infusion pumps with system and pharmacodynamic model adjustment for display and operation
US12514980B2 (en) 2021-06-30 2026-01-06 Insulet Corporation Adjustment of medicament delivery by a medicament delivery device based on menstrual cycle phase
USD1014518S1 (en) * 2021-07-09 2024-02-13 The Regents Of The University Of Colorado, A Body Corporate Display screen or portion thereof with graphical user interface
USD1013704S1 (en) * 2021-07-09 2024-02-06 The Regents Of The University Of Colorado, A Body Corporate Display screen or portion thereof with graphical user interface
US12521486B2 (en) 2021-07-16 2026-01-13 Insulet Corporation Method for modification of insulin delivery during pregnancy in automatic insulin delivery systems
CN113784292B (zh) * 2021-08-24 2022-07-26 同济大学 一种基于手机信令数据的城市疫情风险评估方法
WO2023049900A1 (en) 2021-09-27 2023-03-30 Insulet Corporation Techniques enabling adaptation of parameters in aid systems by user input
USD1112327S1 (en) * 2021-11-03 2026-02-10 Alcon Inc. Display screen or portion thereof with a graphical user interface
USD1112328S1 (en) 2021-11-03 2026-02-10 Alcon Inc. Display screen or portion thereof with a graphical user interface
US20230166037A1 (en) * 2021-11-30 2023-06-01 Tandem Diabetes Care, Inc. System and method of modifying user profile in automated insulin delivery
US11439754B1 (en) 2021-12-01 2022-09-13 Insulet Corporation Optimizing embedded formulations for drug delivery
EP4243030A1 (en) 2022-03-09 2023-09-13 Insulet Corporation Adjusting medicament delivery parameters in an open loop medicament delivery mode
US20250364137A1 (en) * 2022-03-15 2025-11-27 Eveda Ip Pty Ltd A computer system for diagnostic assessments and a method thereof
CN114903648B (zh) * 2022-05-09 2022-11-22 北京理工大学 一种基于eso和模型预测控制的双激素人工胰腺控制器
US20230414872A1 (en) * 2022-06-24 2023-12-28 Peking University Drug injection device based on electrochemical reaction and fabrication method for drug injection pump
USD1117222S1 (en) * 2022-08-11 2026-03-10 Healthpartners Institute Display screen with graphical user interface
EP4646726A1 (en) 2023-01-06 2025-11-12 Insulet Corporation Automatically or manually initiated meal bolus delivery with subsequent automatic safety constraint relaxation
WO2024238318A2 (en) * 2023-05-12 2024-11-21 Insulet Corporation Methods to demonstrate progress towards full adaptation and to present potential improvements through behavioral changes

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007525276A (ja) 2004-02-26 2007-09-06 デックスコム・インコーポレーテッド 持続的ブドウ糖センサのための統合化された投与装置
JP2012024521A (ja) 2010-07-28 2012-02-09 Seiko Epson Corp 血糖値予測装置
JP2014500051A (ja) 2010-10-31 2014-01-09 トラスティーズ オブ ボストン ユニバーシティ 血糖制御システム
JP2017511911A (ja) 2014-01-31 2017-04-27 トラスティーズ オブ ボストン ユニバーシティ 先行する期間に基づくオフライングルコースレベル制御
JP2019509770A (ja) 2016-01-05 2019-04-11 ビッグフット バイオメディカル インコーポレイテッドＢｉｇｆｏｏｔ Ｂｉｏｍｅｄｉｃａｌ， Ｉｎｃ． 動作するマルチモーダル薬剤デリバリ・システム

Family Cites Families (140)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6241704B1 (en) 1901-11-22 2001-06-05 Sims Deltec, Inc. Drug pump systems and methods
US4280494A (en) 1979-06-26 1981-07-28 Cosgrove Robert J Jun System for automatic feedback-controlled administration of drugs
US4464170A (en) 1982-09-29 1984-08-07 Miles Laboratories, Inc. Blood glucose control apparatus and method
EP0374140A1 (en) 1987-08-28 1990-06-27 The Regents Of The University Of Minnesota Metabolic sensor for a drug delivery system
US5665065A (en) 1995-05-26 1997-09-09 Minimed Inc. Medication infusion device with blood glucose data input
US6554798B1 (en) 1998-08-18 2003-04-29 Medtronic Minimed, Inc. External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities
US6669663B1 (en) 1999-04-30 2003-12-30 Medtronic, Inc. Closed loop medicament pump
US6925393B1 (en) 1999-11-18 2005-08-02 Roche Diagnostics Gmbh System for the extrapolation of glucose concentration
DE10006044A1 (de) 2000-02-10 2001-08-16 Roche Diagnostics Gmbh Anordnung und Verfahren zur Dosierung eines die Blutglukose eines Patienten regulierenden Hormons
US6572542B1 (en) 2000-03-03 2003-06-03 Medtronic, Inc. System and method for monitoring and controlling the glycemic state of a patient
US7460130B2 (en) 2000-09-26 2008-12-02 Advantage 3D Llc Method and system for generation, storage and distribution of omni-directional object views
US20030073609A1 (en) 2001-06-29 2003-04-17 Pinkerton Thomas C. Enhanced pharmacokinetic profile of intradermally delivered substances
US6544212B2 (en) 2001-07-31 2003-04-08 Roche Diagnostics Corporation Diabetes management system
US6827702B2 (en) 2001-09-07 2004-12-07 Medtronic Minimed, Inc. Safety limits for closed-loop infusion pump control
US20080172026A1 (en) 2006-10-17 2008-07-17 Blomquist Michael L Insulin pump having a suspension bolus
US6852104B2 (en) 2002-02-28 2005-02-08 Smiths Medical Md, Inc. Programmable insulin pump
GB0206792D0 (en) 2002-03-22 2002-05-01 Leuven K U Res & Dev Normoglycemia
US20040010207A1 (en) 2002-07-15 2004-01-15 Flaherty J. Christopher Self-contained, automatic transcutaneous physiologic sensing system
DE60328039D1 (de) 2002-10-11 2009-07-30 Becton Dickinson Co Insulinabgabesystem mit Sensor
US7655618B2 (en) 2002-12-27 2010-02-02 Diobex, Inc. Compositions and methods for the prevention and control of insulin-induced hypoglycemia
US9872890B2 (en) 2003-03-19 2018-01-23 Paul C. Davidson Determining insulin dosing schedules and carbohydrate-to-insulin ratios in diabetic patients
US20050182366A1 (en) 2003-04-18 2005-08-18 Insulet Corporation Method For Visual Output Verification
US20040253736A1 (en) 2003-06-06 2004-12-16 Phil Stout Analytical device with prediction module and related methods
US7729306B2 (en) 2003-07-24 2010-06-01 Qualcomm Incorporated Method and apparatus for providing a service threshold indicator in a wireless communication system
DE102004011135A1 (de) 2004-03-08 2005-09-29 Disetronic Licensing Ag Verfahren und Vorrichtung zum Berechnen einer Bolusmenge
WO2005113036A1 (en) 2004-05-13 2005-12-01 The Regents Of The University Of California Method and apparatus for glucose control and insulin dosing for diabetics
US7727147B1 (en) 2004-05-14 2010-06-01 Flint Hills Scientific Llc Method and system for implantable glucose monitoring and control of a glycemic state of a subject
EP1881786B1 (en) 2005-05-13 2017-11-15 Trustees of Boston University Fully automated control system for type 1 diabetes
US20060272652A1 (en) 2005-06-03 2006-12-07 Medtronic Minimed, Inc. Virtual patient software system for educating and treating individuals with diabetes
US20070033074A1 (en) * 2005-06-03 2007-02-08 Medtronic Minimed, Inc. Therapy management system
US20060276771A1 (en) 2005-06-06 2006-12-07 Galley Paul J System and method providing for user intervention in a diabetes control arrangement
US7766829B2 (en) 2005-11-04 2010-08-03 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
CN100446724C (zh) 2005-11-28 2008-12-31 中国科学院电子学研究所 用于闭环胰岛素注射的无创血糖仪
US9392969B2 (en) * 2008-08-31 2016-07-19 Abbott Diabetes Care Inc. Closed loop control and signal attenuation detection
US8478557B2 (en) 2009-07-31 2013-07-02 Abbott Diabetes Care Inc. Method and apparatus for providing analyte monitoring system calibration accuracy
US20070255126A1 (en) 2006-04-28 2007-11-01 Moberg Sheldon B Data communication in networked fluid infusion systems
JP4918285B2 (ja) 2006-05-24 2012-04-18 シスメックス株式会社 生体器官の機能のシミュレーションシステム及びそのプログラム
US8548544B2 (en) 2006-06-19 2013-10-01 Dose Safety System, method and article for controlling the dispensing of insulin
US20110054391A1 (en) 2006-07-28 2011-03-03 Ward W Kenneth Analyte sensing and response system
WO2008057384A2 (en) 2006-11-02 2008-05-15 The University Of North Carolina At Chapel Hill Methods and systems for determining an intravenous insulin infusion rate
US7654127B2 (en) 2006-12-21 2010-02-02 Lifescan, Inc. Malfunction detection in infusion pumps
US7946985B2 (en) * 2006-12-29 2011-05-24 Medtronic Minimed, Inc. Method and system for providing sensor redundancy
US10154804B2 (en) 2007-01-31 2018-12-18 Medtronic Minimed, Inc. Model predictive method and system for controlling and supervising insulin infusion
AU2008227836A1 (en) 2007-03-19 2008-09-25 Medingo Ltd. User interface for selecting bolus doses in a drug delivery device
EP1983456B1 (de) 2007-04-19 2013-08-14 F.Hoffmann-La Roche Ag Verfahren zum Einstellen eines Basalratenprofils für eine Insulinpumpe
US20080269714A1 (en) 2007-04-25 2008-10-30 Medtronic Minimed, Inc. Closed loop/semi-closed loop therapy modification system
US20100145262A1 (en) 2007-05-03 2010-06-10 Novo Nordisk A/S Safety system for insulin delivery advisory algorithms
US7751907B2 (en) 2007-05-24 2010-07-06 Smiths Medical Asd, Inc. Expert system for insulin pump therapy
EP2174128B8 (en) 2007-06-20 2017-01-11 Roche Diabetes Care GmbH Method and device for assessing carbohydrate-to-insulin ratio
EP2166946B1 (en) 2007-06-21 2019-11-20 University Of Virginia Patent Foundation Lqg artificial pancreas control system and related method
WO2009001349A1 (en) 2007-06-25 2008-12-31 Medingo Ltd. Tailored basal insulin delivery system
EP2562664B1 (en) 2007-06-27 2020-11-25 Roche Diabetes Care GmbH System for determining an insulin delivery and communicating a dose in automated pancreas software
US10231077B2 (en) 2007-07-03 2019-03-12 Eingot Llc Records access and management
BRPI0813708A2 (pt) 2007-07-09 2014-12-30 Univ Virginia Patent Found Método, sistema e produto de programa de computador para avaliação de sensibilidade a insulina, coeficiente de insulina / carboidrato, e fatores de correção de insulina em diabetes a partir de dados de auto-monitoramento
US20090036753A1 (en) 2007-07-31 2009-02-05 King Allen B Continuous glucose monitoring-directed adjustments in basal insulin rate and insulin bolus dosing formulas
US7717903B2 (en) 2007-09-06 2010-05-18 M2 Group Holdings, Inc. Operating an infusion pump system
CN102670209A (zh) 2007-09-07 2012-09-19 泰尔茂株式会社 血糖值测量方法
US7935105B2 (en) * 2007-09-07 2011-05-03 Asante Solutions, Inc. Data storage for an infusion pump system
US8377031B2 (en) 2007-10-23 2013-02-19 Abbott Diabetes Care Inc. Closed loop control system with safety parameters and methods
WO2009059187A1 (en) 2007-11-02 2009-05-07 University Of Virginia Patent Foundation Predictive control based system and method for control of insulin delivery in diabetes using glucose sensing
US8290559B2 (en) 2007-12-17 2012-10-16 Dexcom, Inc. Systems and methods for processing sensor data
US20090164239A1 (en) 2007-12-19 2009-06-25 Abbott Diabetes Care, Inc. Dynamic Display Of Glucose Information
US20090177154A1 (en) 2008-01-08 2009-07-09 Michael Blomquist Insulin pump with convenience features
US20090177142A1 (en) 2008-01-09 2009-07-09 Smiths Medical Md, Inc Insulin pump with add-on modules
CA2720304C (en) 2008-04-04 2018-05-15 Hygieia, Inc. Apparatus for optimizing a patient's insulin dosage regimen
CN201186082Y (zh) 2008-05-05 2009-01-28 王安宇 胰岛素、葡萄糖智能输入装置
US7959598B2 (en) 2008-08-20 2011-06-14 Asante Solutions, Inc. Infusion pump systems and methods
US8622988B2 (en) 2008-08-31 2014-01-07 Abbott Diabetes Care Inc. Variable rate closed loop control and methods
US8527208B2 (en) 2008-11-17 2013-09-03 Roche Diagnostics International Ag Prandial blood glucose excursion optimization method via computation of time-varying optimal insulin profiles and system thereof
US9317657B2 (en) 2008-11-26 2016-04-19 University Of Virginia Patent Foundation Method, system, and computer program product for tracking of blood glucose variability in diabetes
BRPI1008842B1 (pt) 2009-02-04 2021-04-13 Sanofi-Aventis Deutschland Gmbh Dispositivo e método médicos para proporcionarem um controle glicêmico com base em informações de resposta glicêmica
CN102369032B (zh) 2009-02-04 2015-09-30 赛诺菲-安万特德国有限公司 用于提供用于血糖控制的信息的医疗系统和方法
US8562587B2 (en) 2009-02-25 2013-10-22 University Of Virginia Patent Foundation CGM-based prevention of hypoglycemia via hypoglycemia risk assessment and smooth reduction of insulin delivery
KR20120047841A (ko) 2009-02-26 2012-05-14 몰 리서치 어플리케이션스 엘티디 당뇨병 관련 치료의 자동 감시를 위한 방법 및 시스템
US20100256466A1 (en) 2009-04-02 2010-10-07 Avraham Shekalim Metabolite Management System
EP2435962B1 (en) 2009-05-29 2023-04-19 University of Virginia Patent Foundation System coordinator and modular architecture for open-loop and closed-loop control of diabetes
DK3173014T4 (da) 2009-07-23 2026-03-30 Abbott Diabetes Care Inc Realtidsstyring af data vedrørende fysiologisk kontrol af glucoseniveauer
WO2011028731A1 (en) 2009-09-01 2011-03-10 University Of Virginia Patent Foundation System, method and computer program product for adjustment of insulin delivery (aid) in diabetes using nominal open-loop profiles
WO2011033509A1 (en) 2009-09-18 2011-03-24 Medingo Ltd. Devices, systems and methods for quantifying bolus doses according to user parameters
JP5728767B2 (ja) 2009-09-30 2015-06-03 ドリームド・ダイアベティス・リミテッド インスリン送達の管理のための監視システム、方法、およびコンピュータプログラム
US8690820B2 (en) 2009-10-06 2014-04-08 Illinois Institute Of Technology Automatic insulin pumps using recursive multivariable models and adaptive control algorithms
WO2011050337A1 (en) * 2009-10-22 2011-04-28 Abbott Diabetes Care Inc. Methods for modeling insulin therapy requirements
US20110098638A1 (en) 2009-10-27 2011-04-28 Medtronic Minimed, Inc. Sensor-Augmented Medication Infusion System
CA2779479C (en) 2009-11-04 2020-03-31 Hygieia Inc. Apparatus and methods for taking blood glucose measurements and recommending insulin doses
EP2496289A4 (en) 2009-11-04 2013-06-26 Aimedics Pty Ltd SYSTEM AND METHOD FOR INTEGRATING HYPOGLY KEMIA ALARMS THROUGH COLLECTED DATA IN GLYCOME CONTROL SYSTEMS WITH CLOSED CONTROL CIRCUITS
JP5750123B2 (ja) 2010-02-11 2015-07-15 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 生物学的因子又は薬物を被検者に送達するためのシステム、装置及び方法
US8579879B2 (en) * 2010-02-19 2013-11-12 Medtronic Minimed, Inc. Closed-loop glucose control startup
EP4183326B1 (en) 2010-03-26 2026-01-28 University Of Virginia Patent Foundation Method, system, and computer program product for improving the accuracy of glucose sensors using insulin delivery observation in diabetes
US9445757B2 (en) 2010-12-29 2016-09-20 Medtronic Minimed, Inc. Glycemic health metric determination and application
AU2012272668B2 (en) 2011-06-23 2017-02-02 University Of Virginia Patent Foundation Unified platform for monitoring and control of blood glucose levels in diabetic patients
WO2013019852A2 (en) 2011-08-01 2013-02-07 Tandem Diabetes Care, Inc. Therapy management system
GB2493712B (en) 2011-08-12 2014-07-02 Gene Onyx Ltd Insulin pump
US8745298B2 (en) 2011-10-24 2014-06-03 Roche Diagnostics Operations, Inc. Interoperability enhancement that supports connectivity of applications on a medical device
US10694983B2 (en) 2012-01-19 2020-06-30 Medtronic Minimed, Inc. Method and/or system for assessing a patient's glycemic response
US9883834B2 (en) 2012-04-16 2018-02-06 Farid Amirouche Medication delivery device with multi-reservoir cartridge system and related methods of use
US9238100B2 (en) 2012-06-07 2016-01-19 Tandem Diabetes Care, Inc. Device and method for training users of ambulatory medical devices
US9662445B2 (en) 2012-08-30 2017-05-30 Medtronic Minimed, Inc. Regulating entry into a closed-loop operating mode of an insulin infusion system
US9901677B2 (en) 2012-10-16 2018-02-27 Bigfoot Biomedical, Inc. Infusion pump system and methods
US9486578B2 (en) 2012-12-07 2016-11-08 Animas Corporation Method and system for tuning a closed-loop controller for an artificial pancreas
US9907909B2 (en) 2012-12-20 2018-03-06 Animas Corporation Method and system for a hybrid control-to-target and control-to-range model predictive control of an artificial pancreas
SG11201504861SA (en) 2012-12-21 2015-07-30 Deka Products Lp System and apparatus for electronic patient care using web services
US9351670B2 (en) 2012-12-31 2016-05-31 Abbott Diabetes Care Inc. Glycemic risk determination based on variability of glucose levels
WO2014110541A1 (en) 2013-01-14 2014-07-17 The Regents Of University Of California Daily periodic target-zone modulation in the model predictive control problem for artificial pancreas for type i diabetes applications
US9492608B2 (en) 2013-03-15 2016-11-15 Tandem Diabetes Care, Inc. Method and device utilizing insulin delivery protocols
US10016561B2 (en) 2013-03-15 2018-07-10 Tandem Diabetes Care, Inc. Clinical variable determination
US9517306B2 (en) 2013-03-15 2016-12-13 Animas Corporation Method and system for closed-loop control of an artificial pancreas
WO2015021041A2 (en) * 2013-08-05 2015-02-12 Hygieia, Inc. Systems, devices, and methods for alleviating glucotoxicity and restoring pancreatic beta-cell function in advanced diabetes mellitus
EP2851823A1 (en) 2013-09-20 2015-03-25 Sanofi-Aventis Deutschland GmbH Data management unit for supporting health control
US10569015B2 (en) 2013-12-02 2020-02-25 Bigfoot Biomedical, Inc. Infusion pump system and method
US10925536B2 (en) 2014-01-03 2021-02-23 University Of Virginia Patent Foundation Systems of centralized data exchange for monitoring and control of blood glucose
US9486580B2 (en) 2014-01-31 2016-11-08 Aseko, Inc. Insulin management
US9399096B2 (en) 2014-02-06 2016-07-26 Medtronic Minimed, Inc. Automatic closed-loop control adjustments and infusion systems incorporating same
GB201407896D0 (en) * 2014-05-05 2014-06-18 Joanneum Res Forschungsgmbh Insulin dosage proposal system
EP3148419A4 (en) 2014-05-27 2018-01-24 ResMed Limited Remote respiratory therapy device management
EP4233936A3 (en) 2014-06-10 2023-11-01 Bigfoot Biomedical, Inc. Insulin delivery systems and methods
US9629901B2 (en) 2014-07-01 2017-04-25 Bigfoot Biomedical, Inc. Glucagon administration system and methods
CN104667368B (zh) 2015-03-06 2017-08-15 上海交通大学 控制与计算分离的胰岛素泵动态控制实现方法
CN104667379B (zh) 2015-03-06 2017-08-15 上海交通大学 动态闭环控制的胰岛素泵
JP6684820B2 (ja) 2015-03-24 2020-04-22 アレス トレーディング ソシエテ アノニム 患者ケアシステム
WO2017027459A1 (en) 2015-08-07 2017-02-16 Trustees Of Boston University Glucose control system with automatic adaptation of glucose target
WO2017031440A1 (en) * 2015-08-20 2017-02-23 Aseko, Inc. Diabetes management therapy advisor
US10569016B2 (en) 2015-12-29 2020-02-25 Tandem Diabetes Care, Inc. System and method for switching between closed loop and open loop control of an ambulatory infusion pump
US10806859B2 (en) 2016-01-14 2020-10-20 Bigfoot Biomedical, Inc. Adjusting insulin delivery rates
US9980140B1 (en) 2016-02-11 2018-05-22 Bigfoot Biomedical, Inc. Secure communication architecture for medical devices
US10426342B2 (en) 2016-03-31 2019-10-01 Zoll Medical Corporation Remote access for ambulatory medical device
US20200254240A1 (en) * 2016-05-15 2020-08-13 Biolinq, Inc. Devices and Methods For The Incorporation Of A Microneedle Array Analyte-Selective Sensor Into An Infusion Set, Patch Pump, Or Automated Therapeutic Delivery System
US10937536B2 (en) 2016-07-15 2021-03-02 Universität Bern Estimation of insulin based on reinforcement learning
US10994077B2 (en) 2016-07-21 2021-05-04 Tandem Diabetes Care, Inc. Enhanced confirmations for touchscreen infusion pump
US10896245B2 (en) 2016-08-29 2021-01-19 Bigfoot Biomedical, Inc. Network topology for insulin pump systems
US11033682B2 (en) 2017-01-13 2021-06-15 Bigfoot Biomedical, Inc. Insulin delivery methods, systems and devices
US10881792B2 (en) * 2017-01-13 2021-01-05 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
EP3600519A4 (en) 2017-03-29 2021-01-13 Becton, Dickinson and Company SYSTEM AND METHOD FOR OPERATING THE CONTROL DEVICE OF A DISPENSING DEVICE WITH FLASHES AND TAPS TO CONFIRM A FUNCTION
US11147920B2 (en) 2017-04-18 2021-10-19 Lifescan Ip Holdings, Llc Diabetes management system with automatic basal and manual bolus insulin control
DE202018006860U1 (de) 2017-10-30 2023-11-20 Dexcom, Inc. Diabetes-Management-Partner-Schnittstelle zur drahtlosen Übertragung von Analytdaten
US11424027B2 (en) 2017-12-28 2022-08-23 Cilag Gmbh International Method for operating surgical instrument systems
US11565043B2 (en) 2018-05-04 2023-01-31 Insulet Corporation Safety constraints for a control algorithm based drug delivery system
US11957876B2 (en) 2019-07-16 2024-04-16 Beta Bionics, Inc. Glucose control system with automated backup therapy protocol generation
WO2021011697A1 (en) 2019-07-16 2021-01-21 Beta Bionics, Inc. Blood glucose control system
EP3998943A4 (en) 2019-07-16 2023-09-06 Beta Bionics, Inc. Blood glucose control system
WO2021183611A1 (en) 2020-03-10 2021-09-16 Trustees Of Boston University Integrated user-defined input into a closed-loop glucose control system

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007525276A (ja) 2004-02-26 2007-09-06 デックスコム・インコーポレーテッド 持続的ブドウ糖センサのための統合化された投与装置
JP2012024521A (ja) 2010-07-28 2012-02-09 Seiko Epson Corp 血糖値予測装置
JP2014500051A (ja) 2010-10-31 2014-01-09 トラスティーズ オブ ボストン ユニバーシティ 血糖制御システム
JP2017511911A (ja) 2014-01-31 2017-04-27 トラスティーズ オブ ボストン ユニバーシティ 先行する期間に基づくオフライングルコースレベル制御
JP2019509770A (ja) 2016-01-05 2019-04-11 ビッグフット バイオメディカル インコーポレイテッドＢｉｇｆｏｏｔ Ｂｉｏｍｅｄｉｃａｌ， Ｉｎｃ． 動作するマルチモーダル薬剤デリバリ・システム

Also Published As

Publication number Publication date
US10940267B2 (en) 2021-03-09
DE112020003392T5 (de) 2022-05-19
US20210299352A1 (en) 2021-09-30
EP3998943A4 (en) 2023-09-06
US11116902B2 (en) 2021-09-14
US11679201B2 (en) 2023-06-20
US20210016006A1 (en) 2021-01-21
US20210016004A1 (en) 2021-01-21
CN114760918A (zh) 2022-07-15
MX2022000670A (es) 2022-05-20
CA3146965C (en) 2025-07-08
US20220062547A1 (en) 2022-03-03
US10960137B2 (en) 2021-03-30
EP3998943A1 (en) 2022-05-25
US20210016005A1 (en) 2021-01-21
CA3146965A1 (en) 2021-02-21
US20210402090A1 (en) 2021-12-30
JP2022541491A (ja) 2022-09-26
US11744947B2 (en) 2023-09-05
US20210016003A1 (en) 2021-01-21
US11766518B2 (en) 2023-09-26
US11040141B2 (en) 2021-06-22
AU2020314831A1 (en) 2022-02-24
IL289857A (en) 2022-03-01
WO2021011738A1 (en) 2021-01-21

Similar Documents

Publication Publication Date Title
JP7682453B2 (ja) 血糖制御システム
JP7607291B2 (ja) 血中グルコース制御システム
US11957876B2 (en) Glucose control system with automated backup therapy protocol generation
JP6243546B2 (ja) 先行する期間に基づくオフライングルコースレベル制御
US20200015760A1 (en) Method to determine individualized insulin sensitivity and optimal insulin dose by linear regression, and related systems
WO2022235714A1 (en) Glucose level control systems and methods
Berget et al. Clinical implementation of the Omnipod 5 automated insulin delivery system: key considerations for training and onboarding people with diabetes
US20230405224A1 (en) Autonomous dose determination for pen delivery of medicament
RU2661715C2 (ru) Способ определения значения допустимого роста глюкозы в крови после приема пищи
US20230381413A1 (en) Time-segmented basal rate adaptation process
Satuluri et al. Review on State-of-Art in Insulin Pump Design and Development
CN111388796B (zh) 注射泵的定时装置和注射泵
WO2023081239A1 (en) Autonomous medicament dose trimming

Legal Events

Date Code Title Description
A529 Written submission of copy of amendment under article 34 pct

Free format text: JAPANESE INTERMEDIATE CODE: A529

Effective date: 20220310

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230714

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230714

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20240828

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240903

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20241203

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250121

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20250422

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250428

R150 Certificate of patent or registration of utility model

Ref document number: 7682453

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150